Alia Ahmad

Dr. Alia Ahmad

The University of Child Health Sciences and Children's Hospital Lahore
+1

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SKSWATHI KALIKI
SWATHI KALIKI
XJXunda Ji
Xunda Ji
YZYihua Zou
Yihua Zou
RRRiffat Rashid
Riffat Rashid
SSSadia Sultana
Sadia Sultana
IFIdo Didi Fabian
Ido Didi Fabian
Background: The relationship between lag time and outcomes in retinoblastoma (RB) is unclear. In this study, we aimed to study the effect of lag time between onset of symptoms and diagnosis of retinoblastoma (RB) in countries based on their national-income and analyse its effect on the outcomes. Methods: We performed a prospective study of 692 patients from 11 RB centres in 10 countries from 1 January 2019 to 31 December 2019. Results: The following factors were significantly different among different countries based on national-income level: age at diagnosis of RB (p = 0.001), distance from home to nearest primary healthcare centre (p = 0.03) and mean lag time between detection of first symptom to visit to RB treatment centre (p = 0.0007). After adjusting for country income, increased lag time between onset of symptoms and diagnosis of RB was associated with higher chances of an advanced tumour at presentation (p < 0.001), higher chances of high-risk histopathology features (p = 0.003), regional lymph node metastasis (p < 0.001), systemic metastasis (p < 0.001) and death (p < 0.001). Conclusions: There is a significant difference in the lag time between onset of signs and symptoms and referral to an RB treatment centre among countries based on national income resulting in significant differences in the presenting features and clinical outcomes.

1 September 2023 in JCO Global Oncology
Verified
Journal Article
Open access
DGDylan Graetz
Dylan Graetz
Alia AhmadAlia Ahmad
Alia Ahmad
MRMuhammad Rafie Raza
Muhammad Rafie Raza
AHAmbreen Hameed
Ambreen Hameed
ANAsma Naheed
Asma Naheed
JMJennifer W. Mack
Jennifer W. Mack
PURPOSE: Communication is a fundamental aspect of patient- and family-centered care. Unfortunately, there is a dearth of evidence regarding pediatric cancer communication in low- and middle-income countries, where over 90% of all children with childhood cancer live. The purpose of this study was to explore barriers and facilitators of quality communication within two pediatric cancer centers in Pakistan. METHODS: Semistructured interviews were conducted with 20 multidisciplinary pediatric cancer clinicians and 18 caregivers of children with cancer at Children's Hospital of Lahore and Indus Hospital in Karachi, Pakistan. Interviews were conducted in English or Urdu, audio-recorded, transcribed, and translated to English. Two researchers coded each transcript using an inductively derived codebook. Thematic content analysis focused on barriers and facilitators of high-quality communication. RESULTS: Pakistani clinicians and caregivers identified factors that affected the quality of patient-centered cancer communication. These included structural factors including setting, available interpreters, documentation, patient volume, teamwork, and financial support. Clinician-level communication barriers and facilitators included communication training, clinician distress/boundaries, and the ability to have recurrent conversations. Patient or family characteristics affecting communication included education, income status, primary language, and geography; the child's specific disease type; and relational elements such as social support, empowerment, and split decision makers. Participants identified existing or potential interventions related to each factor. CONCLUSION: Multilevel factors serve as either barriers or facilitators for pediatric cancer communication in Pakistan. Identification of these elements of communication is an essential step toward interventions aimed at improving patient- and family-centered care in resource limited settings.

5 May 2025 in Ophthalmology
Verified
Journal Article
Closed access
RYRyan T. Yanagihara
Ryan T. Yanagihara
JTJamie S.K. Takayesu
Jamie S.K. Takayesu
ECErin E. Crotty
Erin E. Crotty
XJXunda Ji
Xunda Ji
YZYihua Zou
Yihua Zou
ASAndrew W. Stacey
Andrew W. Stacey

25 September 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
MAMattan Arazi
Mattan Arazi
ABAlona Baum
Alona Baum
SCSandro Casavilca-Zambrano
Sandro Casavilca-Zambrano
SASandra Alarcon-Leon
Sandra Alarcon-Leon
RDRosdali Diaz-Coronado
Rosdali Diaz-Coronado
IFIdo Didi Fabian
Ido Didi Fabian

24 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JRJasmeen Randhawa
Jasmeen Randhawa
Mary KimMary Kim
Mary Kim
APAshley Polski
Ashley Polski
MRMark William Reid
Mark William Reid
KMKristen Mascarenhas
Kristen Mascarenhas
Jesse BerryJesse Berry
Jesse Berry
The protective effects of breastfeeding on various childhood malignancies have been established but an association has not yet been determined for retinoblastoma (RB). We aimed to further investigate the role of breastfeeding in the severity of nonhereditary RB development, assessing relationship to (1) age at diagnosis, (2) ocular prognosis, measured by International Intraocular RB Classification (IIRC) or Intraocular Classification of RB (ICRB) group and success of eye salvage, and (3) extraocular involvement. Analyses were performed on a global dataset subgroup of 344 RB patients whose legal guardian(s) consented to answer a neonatal questionnaire. Patients with undetermined or mixed feeding history, family history of RB, or sporadic bilateral RB were excluded. There was no statistically significant difference between breastfed and formula-fed groups in (1) age at diagnosis (p = 0.20), (2) ocular prognosis measures of IIRC/ICRB group (p = 0.62) and success of eye salvage (p = 0.16), or (3) extraocular involvement shown by International Retinoblastoma Staging System (IRSS) at presentation (p = 0.74), lymph node involvement (p = 0.20), and distant metastases (p = 0.37). This study suggests that breastfeeding neither impacts the sporadic development nor is associated with a decrease in the severity of nonhereditary RB as measured by age at diagnosis, stage of disease, ocular prognosis, and extraocular spread. A further exploration into the impact of diet on children who develop RB is warranted.

8 December 2025 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RARahat Ul Ain
Rahat Ul Ain
FIFiza Ismail
Fiza Ismail
LRLaeeq- Ur- Rehman
Laeeq- Ur- Rehman
RQRabia Qaiser
Rabia Qaiser
Alia AhmadAlia Ahmad
Alia Ahmad
MFMahwish Faizan
Mahwish Faizan
Objective: Primary CNS lymphoma (PCNSL) in children is a rare disease, and this study aimed to document the experience of dealing with this in our geographical and resource settings. Methodology: It was an ambidirectional cohort study conducted at the Department of Pediatric Hematology/Oncology and the Department of Pediatric Neurosurgery at the University of Child Health Sciences, The Children’s Hospital Lahore, Pakistan from March 2024 to December 2024. This study included seven suspected and confirmed cases of PCNSL in children under the age of 16 years who presented to a public-sector specialized center in Pakistan over the three-year study period. Results: A total of seven cases of suspected PCNSL were included in the study. The median age at presentation was eight years, with a female-to-male ratio of 2.5:1. Most commonly presenting with a focal neurological deficit, with a median duration of symptoms of 12 weeks, and a median Lansky performance score of 50. Only 57% (04) of patients underwent surgical resection followed by adjuvant chemotherapy. Overall, 57% (03) of patients died, 29% (02) were lost to follow-up, and only 14% (01) are under treatment. Conclusion: PCNSL in children is equally rare in our part of the world, but has a dismal survival rate. Timely surgical intervention, improved supportive care, and a reduction in treatment abandonment might improve the prognosis.